Dow Dull Except for...
Health Care: Drugs
Oncothyreon Inc. (ONTY: NASDAQ)
$2.00 0.01 | 0.50%
05/20/13 - 04:00 PM ET
Portfolios with ONTY
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- Contributor7 Cancer Drug Stocks to Kno...
- ContributorBreakout Stocks Of The Week...
Latest ONTY Headlines from TheStreet
- 4 Biotech Stocks Under $10 Making Big Moves 04.09.13 | 02:04 pm
- 5 Stocks Under $10 Set to Soar 02.28.13 | 01:02 pm
- 3 Pharma Stocks Leaping on Unusual Volume 01.10.13 | 02:01 pm
- Biotech Stock Mailbag: Amicus, Amarin, Oncothyreon 12.21.12 | 07:12 am
- Stocks Slip as Pessimism Clouds Fiscal-Cliff Talks 12.19.12 | 02:12 pm
- Oncothyreon: A Failed Drug Autopsy Performed By A Short Seller 12.19.12 | 10:12 am
- Stock Futures Rise Ahead of Housing Data 12.19.12 | 07:12 am
- Merck KGaA, Oncothyreon Lung Cancer Drug Fails Late-Stage Study 12.19.12 | 06:12 am
- 4 More Stocks Leaping on Unusual Volume 12.11.12 | 03:12 pm
- First 90 Days of 2013 Are Live or Die For These Biotech Stocks 11.19.12 | 09:11 am
Press Releases for ONTY
- Oncothyreon To Present At Future Leaders In The Biotech Industry Conference - PR Newswire 03.29.13 | 08:03 am
- Oncothyreon Announces Full Year And Fourth Quarter 2012 Financial Results Conference Call - PR Newswire 03.07.13 | 08:03 am
- Oncothyreon To Present At Cowen And Company 33rd Annual Health Care Conference - PR Newswire 02.27.13 | 08:02 am
- Oncothyreon Announces That L-BLP25 (Stimuvax®) Did Not Meet Primary Endpoint Of Improvement In Overall Survival In Pivotal Phase 3 Trial In Patients With Non-Small Cell Lung Cancer - PR Newswire 12.19.12 | 06:12 am
- Oncothyreon Announces Presentations At Upcoming Investment Conferences In November 2012 - PR Newswire 11.07.12 | 08:11 am
- Oncothyreon Announces Third Quarter 2012 Financial Results Conference Call - PR Newswire 10.31.12 | 08:10 am
- Oncothyreon Expands Phase 2 Trial Of Its PI-3 Kinase Inhibitor PX-866 In Patients With Prostate Cancer - PR Newswire 09.05.12 | 08:09 am
- Oncothyreon Announces Presentations At Upcoming Investment Conferences In September 2012 - PR Newswire 08.29.12 | 08:08 am
- Oncothyreon Announces Second Quarter 2012 Financial Results Conference Call - PR Newswire 08.08.12 | 08:08 am
- Oncothyreon To Present At 2012 Wedbush Pacgrow Lifesciences Management Access Conference - PR Newswire 08.08.12 | 08:08 am
Partner Headlines for ONTY
- Stock Watch Thursday, 20 December - Seeking Alpha 12.20.12 | 09:12 am
- Long term spread targets Oncothyreon - NASDAQ 08.30.12 | 04:08 pm
- Reassessing & Continuing To Monitor Portfolios For Success - Seeking Alpha 07.30.12 | 09:07 am
- Oncothyreon Announces Presentation of PX-866 Clinical Data at American Association of Clinical Oncology Annual Meeting - Benzinga 06.02.12 | 06:06 pm
- Must Know Equity Upgrades and Downgrades Wednesday - Wall St. Cheat Sheet 05.23.12 | 03:05 am
- Interesting Reaction To Oncothyreon's Share Offering - Seeking Alpha 03.30.12 | 08:03 am
- Cytori Is A Compelling Short Sale Opportunity - Seeking Alpha 03.19.12 | 09:03 am
- Oncothyreon And Lpath: Shares Collapsed, Primed For A Rebound? - Seeking Alpha 03.09.12 | 09:03 am
- Immunocellular Again Pushing To $2 - Seeking Alpha 02.15.12 | 09:02 am
- Stocks To Watch Week Of Feb. 6 - Seeking Alpha 02.06.12 | 08:02 am
